Form D · Other
Orchid Labs Inc.
San Francisco, CA · CIK 0001721086
Offering snapshot reported Apr 20, 2018 · SEC filing
- Reported sold
- $36.1M Offering amount: $126M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 20, 2018 | Initial | $36,128,073 | No comparison | 42 | SEC filing |
| Nov 9, 2017 | Initial | $4,500,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-310739
The ongoing offering reported herein is in addition to a prior offering made under a claim of federal exemption under Rule 506(b). The issuer may pursue one or more subsequent offering following the termination of this offering.
Sale and issuance of rights to receive tokens in the future via a Simple Agreement for Future Tokens (SAFTs)
Source: Form D, filed Apr 20, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Francis Bell | Director, Executive |
| Brian Fox | Director, Executive |
| Jay Freeman | Director |
| Gustav Simonsson | Director |
| Steven Richard Waterhouse | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
182 Howard Street #423
San Francisco, CA, 94105
San Francisco, CA, 94105